NEITHER THIS WARRANT NOR THE SECURITIES INTO WHICH THIS WARRANT IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE...Warrant Agreement • December 8th, 2010 • Weikang Bio-Technology Group Co., Inc. • Medicinal chemicals & botanical products
Contract Type FiledDecember 8th, 2010 Company IndustryThis Warrant is being issued pursuant to an engagement letter, dated September 30, 2010, by and between the Company and the Initial Holder (the “Engagement Letter”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 8th, 2010 • Weikang Bio-Technology Group Co., Inc. • Medicinal chemicals & botanical products
Contract Type FiledDecember 8th, 2010 Company IndustryThis Agreement is made pursuant to separate Subscription Agreements, dated as of the date hereof, between the Company and each Purchaser (the “Subscription Agreements”).
LOCK-UP AGREEMENTLock-Up Agreement • December 8th, 2010 • Weikang Bio-Technology Group Co., Inc. • Medicinal chemicals & botanical products • California
Contract Type FiledDecember 8th, 2010 Company Industry JurisdictionTHIS AGREEMENT (this “Agreement”) is dated as of December 2, 2010 by and between Weikang Bio-Technology Group Company, Inc., a Nevada corporation (the “Company”), and ____________ (“Shareholder”).
INVESTOR AND PUBLIC RELATIONS ESCROW AGREEMENTInvestor and Public Relations Escrow Agreement • December 8th, 2010 • Weikang Bio-Technology Group Co., Inc. • Medicinal chemicals & botanical products • New York
Contract Type FiledDecember 8th, 2010 Company Industry JurisdictionThis Agreement, dated as of December 2, 2010 (this “Agreement”), is entered into by and among Weikang Bio-Technology Group Company, Inc., a Nevada corporation (the “Company”), Sichenzia Ross Friedman Ference LLP (the “Escrow Agent”), and MidSouth Investor Fund LP, as representative for the Subscribers in that certain Subscription Agreement (as defined herein) (“Subscriber Representative) (the Company and the Subscriber Representative are collectively referred to as “Escrowing Parties”).
MAKE GOOD SECURITIES ESCROW AGREEMENTMake Good Securities Escrow Agreement • December 8th, 2010 • Weikang Bio-Technology Group Co., Inc. • Medicinal chemicals & botanical products • New York
Contract Type FiledDecember 8th, 2010 Company Industry JurisdictionTHIS MAKE GOOD SECURITIES ESCROW AGREEMENT (the “Make Good Agreement” or the “Agreement”), dated as of December 2, 2010, is entered into by and among Weikang Bio-Technology Group Company, Inc., a Nevada corporation (the “Company”), Lucky Wheel Limited (the “Principal Shareholder”) and Sichenzia Ross Friedman Ference LLP with an address at 61 Broadway, 32nd Floor, New York, NY 10006 (the “Escrow Agent”).
ESCROW DEPOSIT AGREEMENTEscrow Deposit Agreement • December 8th, 2010 • Weikang Bio-Technology Group Co., Inc. • Medicinal chemicals & botanical products • New York
Contract Type FiledDecember 8th, 2010 Company Industry JurisdictionThis ESCROW DEPOSIT AGREEMENT (this “Agreement”) dated as of this 25th day of October, 2010, by and among Weikang Bio-Technology Group Company, Inc., a Nevada corporation (the “Company”), having an address at No. 365 Chengde Street, Daowai District, Harbin Heilongjiang Province, The People’s Republic of China 150020, Hunter Wise Securities, LLC, a California limited liability company (“Placement Agent”), having an address at 2361 Campus Drive, Suite 100, Irvine, CA 92612, and SIGNATURE BANK (the “Escrow Agent”), a New York State chartered bank, having an office at 950 Third Avenue, 9th Floor, New York, NY 10022. All capitalized terms not herein defined shall have the meaning ascribed to them in that certain Confidential Private Placement Memorandum, dated October 25. 2010 as amended or supplemented from time-to-time, including all attachments, schedules and exhibits thereto (the “Memorandum”).